Literature DB >> 3934775

Treatment of epidermoid carcinoma of the anal canal.

M J Greenall, S H Quan, C Urmacher, J J DeCosse.   

Abstract

Epidermoid carcinoma of the anal canal should be differentiated from that of the anal margin because of the different clinical presentations, pathologic characteristics, treatments and prognosis. The traditional treatment for carcinoma of the canal, abdominoperineal resection, produced a 55 per cent absolute five year survival rate but at the expense of permanent colostomy. Initial treatment with 5-fluorouracil and mitomycin C combined with external beam radiation therapy reduced the size of the tumor in 72 per cent of the patients and, with subsequent local excision or abdominoperineal resection, resulted in a 78 per cent survival rate in five years. The long term results from combined treatment are better than abdominoperineal resection alone with preservation of anal function in 45 per cent of the patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934775

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  16 in total

1.  Salvage abdominoperineal resection and perineal wound healing in local recurrent or persistent anal cancer.

Authors:  Floris T J Ferenschild; Maarten Vermaas; Stefan O Hofer; Cornelis Verhoef; Alexander M M Eggermont; Johannes H W de Wilt
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

Review 2.  HDR brachytherapy for anal cancer.

Authors:  Peter Niehoff; Gyoergy Kovács
Journal:  J Gastrointest Oncol       Date:  2014-06

Review 3.  Treatment of primary epidermoid carcinoma of the anal canal.

Authors:  B J Cummings
Journal:  Int J Colorectal Dis       Date:  1987-06       Impact factor: 2.571

4.  Epidermoid cancer of the anal canal.

Authors:  Shawn P Webb; Chong S Lee
Journal:  Clin Colon Rectal Surg       Date:  2011-09

5.  ACR Appropriateness Criteria®-Anal Cancer.

Authors:  Theodore S Hong; Jennifer L Pretz; Joseph M Herman; May Abdel-Wahab; Nilofer Azad; A William Blackstock; Prajnan Das; Karyn A Goodman; Salma K Jabbour; William E Jones; Andre A Konski; Albert C Koong; Miguel Rodriguez-Bigas; William Small; Charles R Thomas; Jennifer Zook; W Warren Suh
Journal:  Gastrointest Cancer Res       Date:  2014-01

6.  Anal canal squamous cell cancer: are surgical alternatives to chemoradiation just as effective?

Authors:  Kunal Suradkar; Emmanouil E Pappou; Steven A Lee-Kong; Daniel L Feingold; Ravi P Kiran
Journal:  Int J Colorectal Dis       Date:  2017-12-21       Impact factor: 2.571

Review 7.  Anal cancer treatment: current status and future perspectives.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Pamela Abdayem; Joelle Antoun; Dolly Nasr
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

8.  Endoanal ultrasonography in the follow-up of anal carcinoma.

Authors:  U Herzog; M Boss; H P Spichtin
Journal:  Surg Endosc       Date:  1994-10       Impact factor: 4.584

9.  Combined chemoradiation therapy for anal cancer. A report of 56 cases.

Authors:  R Doci; R Zucali; L Bombelli; F Montalto; G Lamonica
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

10.  Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.

Authors:  W E Longo; A M Vernava; T P Wade; M A Coplin; K S Virgo; F E Johnson
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.